Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.
This study has been completed.
Genzyme, a Sanofi Company
Diacrin/Genzyme Corporation LLC
Information provided by:
First received: September 23, 2005
Last updated: March 17, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||January 2001|
|Estimated Primary Completion Date:||No date given|